This obesity-mediated inflammation through NLRP3 inflammasome results in a further deterioration of metabolic control leading to metabolic disorders such as non-alcoholic fatty liver disease (NAFLD) [22]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.